148 related articles for article (PubMed ID: 23682394)
1. Results from the AHA late-breaking trials on cell-based therapies.
Taylor J
Eur Heart J; 2013 Apr; 34(14):1016-7. PubMed ID: 23682394
[No Abstract] [Full Text] [Related]
2. Bone marrow-derived cell therapy after myocardial infarction--reply.
Marbán E; Malliaras K
JAMA; 2013 Apr; 309(14):1459-60. PubMed ID: 23571575
[No Abstract] [Full Text] [Related]
3. Mixed results for bone marrow–derived cell therapy for ischemic heart disease.
Marbán E; Malliaras K
JAMA; 2012 Dec; 308(22):2405-6. PubMed ID: 23117584
[No Abstract] [Full Text] [Related]
4. Bone marrow-derived cell therapy after myocardial infarction.
Moyé LA; Simari RD; Skarlatos SI;
JAMA; 2013 Apr; 309(14):1459. PubMed ID: 23571574
[No Abstract] [Full Text] [Related]
5. [Stem cell therapy in ischemic heart disease].
Diederichsen AC; Møller JE; Kristiansen MA; Saekmose SG; Barington T; Videbaek LM; Kassem MS; Thayssen P
Ugeskr Laeger; 2006 Mar; 168(11):1111-4. PubMed ID: 16545213
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow cell therapy after myocardial infarction. What should we select?
Landmesser U
Eur Heart J; 2009 Jun; 30(11):1310-2. PubMed ID: 19429633
[No Abstract] [Full Text] [Related]
7. Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy.
Trachtenberg B; Velazquez DL; Williams AR; McNiece I; Fishman J; Nguyen K; Rouy D; Altman P; Schwarz R; Mendizabal A; Oskouei B; Byrnes J; Soto V; Tracy M; Zambrano JP; Heldman AW; Hare JM
Am Heart J; 2011 Mar; 161(3):487-93. PubMed ID: 21392602
[TBL] [Abstract][Full Text] [Related]
8. [Stem cells after myocardial infarction].
Schächinger V; Dimmeler S; Zeiher AM
Herz; 2006 Apr; 31(2):127-36; quiz 142-3. PubMed ID: 16738836
[TBL] [Abstract][Full Text] [Related]
9. Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of microcirculation.
Grajek S; Popiel M; Gil L; Breborowicz P; Lesiak M; Czepczyński R; Sawiński K; Straburzyńska-Migaj E; Araszkiewicz A; Czyz A; Kozłowska-Skrzypczak M; Komarnicki M
Eur Heart J; 2010 Mar; 31(6):691-702. PubMed ID: 20022872
[TBL] [Abstract][Full Text] [Related]
10. [Stem cell transfer in myocardial infarction].
Dimmeler S; Zeiher AM
Dtsch Med Wochenschr; 2006 Apr; 131(16):881-3. PubMed ID: 16625481
[No Abstract] [Full Text] [Related]
11. Stem cell delivery to the heart: clarifying methodology and mechanism.
Crisostomo PR; Meldrum DR
Crit Care Med; 2007 Nov; 35(11):2654-6. PubMed ID: 18075378
[No Abstract] [Full Text] [Related]
12. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
Traverse JH; Henry TD; Moye' LA
Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659
[TBL] [Abstract][Full Text] [Related]
13. Cell therapy for acute myocardial infarction.
Wollert KC
Curr Opin Pharmacol; 2008 Apr; 8(2):202-10. PubMed ID: 18243051
[TBL] [Abstract][Full Text] [Related]
14. [Regenerative treatment of advanced heart disease].
Leistner DM; Seeger FH; Dimmeler S; Zeiher AM; Assmus B
Dtsch Med Wochenschr; 2012 Apr; 137(14):732-7. PubMed ID: 22454205
[No Abstract] [Full Text] [Related]
15. The REPAIR-AMI and ASTAMI trials: cell isolation procedures.
Egeland T; Brinchmann JE
Eur Heart J; 2007 Sep; 28(17):2174-5; author reply 2175. PubMed ID: 17673446
[No Abstract] [Full Text] [Related]
16. [Regenerative therapy in patients with a revascularized acute anterior myocardial infarction and depressed ventricular function].
Suárez de Lezo J; Herrera C; Pan M; Romero M; Pavlovic D; Segura J; Sánchez J; Ojeda S; Torres A
Rev Esp Cardiol; 2007 Apr; 60(4):357-65. PubMed ID: 17521544
[TBL] [Abstract][Full Text] [Related]
17. PROMETHEUS and POSEIDON: Harnessing the power of advanced cardiac imaging.
Chugh AR; Lima JA
Circ Res; 2014 Apr; 114(8):1222-4. PubMed ID: 24723652
[No Abstract] [Full Text] [Related]
18. Cell therapy for heart failure: the need for a new therapeutic strategy.
Povsic TJ; O'Connor CM
Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1107-26. PubMed ID: 20670189
[TBL] [Abstract][Full Text] [Related]
19. [Stem cell transfer after myocardial infarction--For].
Müller-Ehmsen J
Dtsch Med Wochenschr; 2006 Apr; 131(14):774. PubMed ID: 16596501
[No Abstract] [Full Text] [Related]
20. Autologous transplantation of blood-derived stem/progenitor cells for ischaemic heart disease.
Wen Y; Meng L; Ding Y; Ouyang J
Int J Clin Pract; 2011 Aug; 65(8):858-65. PubMed ID: 21762310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
